Karger.com, 2 months ago
Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? - Paperity, 4 weeks ago
1 images for "lymphocyte count"
EC approves Roche's Gazyvaro in combo with bendamustine for people with previously treated follicular lymphoma
Roche announced that the European Commission has approved Gazyvaro (obinutuzumab) in combination with bendamustine chemotherapy followed by Gazyvaro maintenance in people with follicular lymphoma who did not respond or who progressed during or up to ...PharmaBiz, 2 months ago ROCHE : Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma 4 Traders, 2 months ago Roche's Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma FirstWord Pharma, 2 months ago
Celgene and LYSARC Provide Update on the Phase III REMARC Study of REVLIMID® Maintenance Treatment in Patients with Diffuse Large B-Cell Lymphoma Responding to First-Line R-CHOP Therapy Celgene and LYSARC Provide Update on the Phase III REMARC ...BioSpace, 1 month ago Celgene and LYSARC Provide Update on the Phase III REMARC Study of REVLIMID® Maintenance Treatment in Patients with Diffuse Large B-Cell Lymphoma Responding to First-Line R-CHOP Therapy BioSpace, 1 month ago Genentech Receives a Blow After Lymphoma Drug Flunks Phase III Test BioSpace, 1 month ago Genentech Provides Update on Phase III Study of Gazyva® in People With Previously Untreated Diffuse Large B-Cell Lymphoma Minyanville, 1 month ago
More from: Nasdaq, Business Wire...and 18 other sources
(HealthDay News) -- Skin biopsies from patients co-infected with HIV and syphilis have moderate to extensive lymphoplasmacytic infiltrate, according to research published online June 14 in the Journal of Cutaneous Pathology . Gabriela Rosa, M.D., ...Physician's Briefing, 2 months ago Comprehensive Care Is Key in HIV Management, Pharmacists Say ASHP, 1 week ago 1.5 CPD credits: Non-infective skin disorders in HIV patients Mims.co.uk, 2 months ago
Patients with relapsed or refractory acute myelogenous leukemia (AML) respond to single-agent treatment with the B-cell lymphoma-2 (BCL-2) inhibitor venetoclax (Venclexta), according to the results of a phase II clinical trial published in Cancer ...OncoTherapy Network, 2 weeks ago Telomere length is indicator of blood count recovery in treatment of Acute Myeloid Leukemia HealthMediciNet.com, 1 month ago Venetoclax Drug Shows Promising Results in Patients With Leukemia MedIndia, 2 weeks ago Venetoclax safe, shows guarantee in patients with strident myelogenous leukemia HealthMediciNet.com, 2 weeks ago
By Mark Terry , BioSpace.com Breaking News Staff Speculation that Foster City, California-based Gilead Sciences ( GILD ) will or should buy Bristol-Myers Squibb ( BMY ) have been floating around for at least a year. It has emerged again, largely ...BioSpace, 2 weeks ago
Share this content: Patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib may have a mildly elevated risk of developing Pneumocystis jirovecii pneumonia. Patients with chronic lymphocytic leukemia (CLL) treated with the ...Cancer Therapy Advisor, 2 weeks ago Report Published: "Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016" Digital Journal, 3 weeks ago Acute Lymphocytic Leukemia Market Opportunities, Growth, Size, Share and Forecast Before It's News, 4 weeks ago Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016 Global Information Inc, 1 month ago
More from: , MyNewsDesk...and 3 other sources
Another New Esophagitis: The Lymphocyte Gets Its Turn David A. Katzka 0 1 0 Division of Gastroenterology and Hepatology, Mayo Clinic , 200 First Ave., S.W., Rochester, MN 55905 , USA 1 & David A. Katzka - Establishing the existence of a new disease ...Paperity, 3 weeks ago
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.
Neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in patients with metastatic castration-resistant prostate cancer receiving systemic therapy. However, the prognostic significance of NLR was never previously evaluated in patients who ...UroToday, 1 month ago Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy Gene Therapy, 3 weeks ago
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
Mani et al. Breast Cancer Research Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer Nikita L. Mani 1 Kurt A. Schalper 0 1 Christos Hatzis 0 Ozlen Saglam 2 Fattaneh Tavassoli 1 Meghan Butler 0 ...Paperity, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!